SynthesisBritish journal of clinical pharmacology2026

Clinical evidence of semaglutide for metabolic dysfunction-associated steatotic liver disease (MASLD): An updated meta-analysis.

Tzu-Rong Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.